- Details
- Description
Strength:
25 mg
Composition:
Brensocatib 25 mg
Treatment:
Non-cystic fibrosis bronchiectasis (NCFB)
Form:
Tablets
Brand:
LuciBren
Quantity Unit:
Tablets
Manufacturer:
Luci Pharma
LuciBren 25 mg (Brensocatib) is a prescription medicine containing brensocatib 25 mg. It belongs to the class of selective DPP-1 inhibitors and is used in the treatment of non-cystic fibrosis bronchiectasis. Brensocatib works by reducing the activation of neutrophil serine proteases involved in airway inflammation and tissue damage, helping to reduce airway inflammation and the frequency of pulmonary exacerbations. It is taken orally as directed by a healthcare professional and should be used under medical supervision.
